PGE, or PGE 2 injected iv at different doses (5, 20 or 50 fig/100 g body wt) in ovariectomized rats failed to modify plasma prolactin levels 20, 60 or 90 min after injection. The diluent (95% ethanol) was also ineffective. Third ventricular injection of PGE, (5 fig in 5 fi\ 95% ethanol: 0.02% Na 2 CO 3 , 1:9) in ovariectomized rats induced a marked increase in plasma prolactin levels 15 min later. Levels then declined but were still elevated at 30 min. At 60 min they were not different from the initial values. PGE 2) PGF lQ or PGF 2a at the same dose failed to modify plasma prolactin at any time interval studied. The diluent also did not alter plasma prolactin. Intraventricular injection of different doses of PGE, (0.5, 1.0, 2.5 or 5.0 fig in 5 fil) induced a dose-related increase of plasma prolactin 15 min after the injection. In ovariectomized, estrogen-treated rats (estradiol benzoate, Eb, 10 fig, SC, 48 hr before), PGE, increased plasma prolactin 15 min later, in spite of the elevated initial plasma prolactin levels induced by the estrogen treatment. PGE 2 , PGF la) PGF 2a or the diluent were again ineffective. Intrapituitary injection of PGE, (2.5 fig in 2.5 fi\ into each lobe) in ovariectomized rats slightly increased plasma prolactin levels at 15 min (p < 0.05). Similar injections of PGE 2 did not alter plasma prolactin at any time interval studied. Intrapituitary injections of PGE, or PGE 2 in ovariectomized estrogen-treated rats at the same dose used before failed to increase plasma prolactin. These results indicate that PGE, can stimulate prolactin release by acting on the central nervous system and that this effect is not inhibited by estrogen treatment. PGE 2 , PGF, a and PGF 2a appear to be ineffective. Under certain conditions, PGE, may also stimulate prolactin release by acting on the adenohypophysis, but this effect was inhibited by estrogen pretreatment. (Endocrinology 95: 613, 1974) P ROSTAGLANDIN participation in a wide variety of endocrine and metabolic systems is well documented (1-3); however, little is known about the role played by prostaglandins in the nervous system (4) or in the neural control of pituitary secretion.The first demonstration that prostaglandins could modify the release of pituitary hormones by acting directly on the central nervous system was made by Hedge (5), who reported that PGEi or PGF l a microinjected into the median eminence induced a release of ACTH. In this paper we report in detail results which indicate that PGE X can act on both the CNS and anterior pituitary gland to release prolactin. Preliminary reSprague-Dawley female rats (Simonsen Laboratories, Gilroy, California), weighing 230-300 g, were used. All animals were ovariectomized upon arrival and housed under controlled conditions of light (14 hr on and 10 hr off) and temperature (24 C). Purina rat chow and water were available ad libitum.Intravenous injections. Two weeks after ovariectomy the animals were lightly anesthetized with ether and initial blood samples (0.8-0.9 ml) were drawn from the external j...